logo

Eyenovia, Inc. (EYEN)



Trade EYEN now with
  Date
  Headline
12/19/2018 9:08:32 AM Eyenovia Prices Underwritten Public Offering Of 1.20 Mln Shares At $2.45/shr
12/3/2018 9:32:07 AM Eyenovia Completes Patient Enrollment In MicroStat MIST-1 Study And Enrolls First Patient In MIST-2 Study
11/26/2018 9:08:56 AM Eyenovia Begins Phase III MicroStat Program For Pharmacologic Mydriasis: Enrolls First Patient In MIST-1 Study
11/13/2018 7:36:20 AM Eyenovia Says FDA Accepted IND Application To Initiate Phase III Trials Of MicroStat For Diagnostic Mydriasis
11/13/2018 6:47:30 AM Eyenovia Q3 Net Loss $4.3 Mln Or $0.43/Shr Vs Loss $0.9 Mln Or $0.10/Shr Last Year
8/14/2018 6:33:35 AM Eyenovia Q2 Net Loss $3.3 Mln Or $0.33 Per Share
8/13/2018 8:33:42 AM Eyenovia Announces Positive Results Of Its EYN PG21 Proof-of-concept Study Of Microdose Latanoprost
7/9/2018 7:32:23 AM Eyenovia Appoints Michael Rowe As VP Of Marketing